HTR1A and Alzheimer disease: Initial PET studies have largely confirmed these findings in vivo and demonstrated decreased 5‐HT1A binding in the hippocampus and medial temporal cortex in AD patients, compared to control subjects (Kepe et al., 2006; Lanctôt et al., 2007; Truchot et al., 2007).